A new study shows that CD8-positive T cells play a significant role in the early stages of multiple sclerosis (MS).
A new poll of voters conducted earlier this week shows a very tight race in Colorado's eighth congressional district between ...
GlobalData on MSN1d
NIH selects Emergex’s T cell vaccine for trials under Project NextGen"NIH selects Emergex’s T cell vaccine for trials under Project NextGen" was originally created and published by Clinical ...
Research shows Fc–IL-4 revitalizes exhausted CD8+ T cells, boosting antitumor responses and highlighting the potential of ...
Emergex Vaccines Holding Limited (‘Emergex’, or the ‘Company’), a clinical-stage biotechnology company addressing major global infectious diseases through the development of synthetic T cell-priming ...
LMU researchers demonstrate that certain immune cells already play an important role in the early stages of multiple sclerosis ...
Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...
Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer ...
Nonpathogenic E. coli displaying decoy-resistant IL18 demonstrate potent anti-tumor responses and boost CAR-NK cell ...
Updated clinical results to be presented from the ongoing Phase 1/2 ABILITY-1 study of MDNA11 in advanced or metastatic solid tumorsPreclinical ...
CD8-positive T cells are a critical subpopulation of MHC class I-restricted T cell and are mediators of adaptive immunity. They include cytotoxic T cells, which are important for killing cancerous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback